CF
NVAX icon

Corebridge Financial’s Novavax NVAX Stock Holding History

Corebridge Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,517
Closed -$484K – 1850
2025
Q1 		$484K Sell
75,517
-1,120
-1% -$9.26K ﹤0.01% 1616
2024
Q4 		$616K Buy
76,637
+1,106
+1% +$10.7K ﹤0.01% 1564
2024
Q3 		$954K Sell
75,531
-465
-0.6% -$6K 0.01% 1378
2024
Q2 		$962K Buy
+75,996
New +$765K 0.01% 1354

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Corebridge Financial's NVAX Position: Q2 2025 in Review

Corebridge Financial sold out of Novavax (NVAX) in Q2 2025, closing a stake of 75,517 shares — an estimated $484K sold.

Corebridge Financial first reported a position in NVAX in Q2 2024 and held it in 4 quarters. The position peaked at $962K in Q2 2024. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • Corebridge Financial reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 75,517 Novavax shares in Q2 2025, an estimated $484K.
  • Corebridge Financial first reported a position in Novavax in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Novavax position peaked at $962K in Q2 2024.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.